Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chine… Read more
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.016x
Based on the latest financial reports, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a cash flow conversion efficiency ratio of 0.016x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.54 Million) by net assets (CN¥1.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oma Saastopankki Oyj
HE:OMASP
|
0.532x |
|
Porter Holding International Inc
PINK:ULNV
|
0.002x |
|
GBank Financial Holdings Inc. Common Stock
OTCQX:GBFH
|
-0.077x |
|
Anhui Wantong Technology Co Ltd
SHE:002331
|
-0.056x |
|
Tubacex S.A
MC:TUB
|
0.123x |
|
BTS Group AB (publ)
OTCGREY:BGPBF
|
0.068x |
|
Shenmao Technology Inc
TW:3305
|
-0.070x |
|
SG Fleet Group Ltd
AU:SGF
|
-0.064x |
Annual Cash Flow Conversion Efficiency for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.64 Billion | CN¥156.59 Million | 0.096x | +42.60% |
| 2023-12-31 | CN¥1.55 Billion | CN¥104.05 Million | 0.067x | -49.30% |
| 2022-12-31 | CN¥947.60 Million | CN¥125.36 Million | 0.132x | -7.97% |
| 2021-12-31 | CN¥807.21 Million | CN¥116.04 Million | 0.144x | +14.65% |
| 2020-12-31 | CN¥735.66 Million | CN¥92.24 Million | 0.125x | +24.61% |
| 2019-12-31 | CN¥674.71 Million | CN¥67.89 Million | 0.101x | +31.36% |
| 2018-12-31 | CN¥611.60 Million | CN¥46.85 Million | 0.077x | +49.58% |
| 2017-12-31 | CN¥555.58 Million | CN¥28.45 Million | 0.051x | -72.92% |
| 2016-12-31 | CN¥327.82 Million | CN¥61.99 Million | 0.189x | +34.49% |
| 2015-12-31 | CN¥288.89 Million | CN¥40.62 Million | 0.141x | -28.71% |
| 2014-12-31 | CN¥246.19 Million | CN¥48.56 Million | 0.197x | +63.50% |
| 2013-12-31 | CN¥210.84 Million | CN¥25.43 Million | 0.121x | -- |